Srividya Velagapudi
5PUBLICATIONS
33CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 14, 2025
Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation.Srividya Velagapudi, Melroy X Miranda, Priyanka Adla
|May 13, 2024
Inhibition of de novo ceramide synthesis by sirtuin-1 improves beta-cell function and glucose metabolism in type 2 diabetes.Srividya Velagapudi, Gergely Karsai, Maria Karsai
|Jul 04, 2023
Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress.Kangmin Yang, Srividya Velagapudi, Alexander Akhmedov
|Nov 23, 2021
Posttranscriptional Regulation of the Human LDL Receptor by the U2-Spliceosome.Paolo Zanoni, Grigorios Panteloglou, Alaa Othman
|Aug 19, 2021
Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein.Srividya Velagapudi, Lucia Rohrer, Francesco Poti
Pageof 1
Frequent Collaborators
3 joint publications
Simon Kraler
3 joint publications
Alexander Akhmedov
2 joint publications
Hyun-Duk Jang
2 joint publications
Grigorios Panteloglou
2 joint publications
Hyo-Soo Kim
2 joint publications
Arnold von Eckardstein
2 joint publications
Thomas F Lüscher
2 joint publications
Bart Staels
1 joint publications
Francesco Paneni
1 joint publications
John S Parks
